Clinical Trials

Study Title:
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease.

For more information about the trial above please contact the study team:

Medical University of South Carolina
Principal Investigator, Green, Kimberly, at greekm@musc.edu.
Study Coordinator, Mendiola, Hannah, at mendiola@musc.edu.

Trial opened at the following institutions: Medical University of South Carolina